Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. - Wikidata - wikimedia - TriplyDB

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature.

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature.

http://www.wikidata.org/entity/Q34564716

about

Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence Occupational exposures among nurses and risk of spontaneous abortion Identification of Knowledge Gaps Regarding Healthcare Workers' Exposure to Antineoplastic Drugs: Review of Literature, North America versus Europe Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process Application of ozone gas for decontamination of nucleoside anticancer drugs Causes of Health Care Workers' Exposure to Antineoplastic Drugs: An Exploratory Study Review of hazards to female reproductive health in veterinary practice Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs.A study of handling cytotoxic drugs and risk of birth defects in offspring of female veterinarians.Dispersive solid-phase extraction procedure coupled to UPLC-ESI-MS/MS analysis for the simultaneous determination of thirteen cytotoxic drugs in human urine.Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.Safe handling of parenteral cytotoxics: recommendations for ontario.Environmental hazard in the aetiology of somatic and germ cell aneuploidy.Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.Occupational exposure to anti-cancer drugs: A review of effects of new technology.Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.Avoiding accidental exposure to intravenous cytotoxic drugs.Antineoplastic drug contamination in the urine of Canadian healthcare workers.An update systematic review of fetal death, congenital anomalies, and fertility disorders among health care workers.Current challenges in European oncology pharmacy practice.More than just crushing: a prospective pre-post intervention study to reduce drug preparation errors in patients with feeding tubes.Salient Features and Outline of the Joint Japanese Guidelines for Safe Handling of Cancer Chemotherapy Drugs.Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units.Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.Hospital work and pregnancy outcomes: a study in the Danish National Birth Cohort.Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.A surface wipe sampling and LC-MS/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers.ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice.Knowledge and training needs of nurses and physicians on unsuitable drugs for patients with dysphagia or feeding tubes

P2860

Q23922579-38FB7B62-8C3C-4F15-B040-4510C9641092 Q24169753-A9657DAD-99F4-434C-B6A6-BAB8FDEFD4FB Q27003871-A0334AA1-BBED-4A39-9C52-465032F852E5 Q28386992-A88294F5-50B3-45F5-98EE-3801CB04D7D3 Q28388219-C56F1157-1A3C-49C4-9946-8CCC053DF6B5 Q28390733-9E54B746-3EEE-40A7-A88C-A576BBDDBA41 Q28397950-79C01483-6C77-46D1-BE74-CB1632EC84B5 Q29960440-5733C45A-A63E-4A15-8AB2-D0AB521A83BF Q33693999-4E4073FA-4B2E-4A9C-BA70-171494B44C68 Q33834003-4AE61CCA-4461-40E1-81FE-FE75741E78BF Q35893243-7B651D32-B082-48C3-BCC4-B2130BC4F8D2 Q36758912-4C8BAA43-AC8F-4D38-A952-9B387BB3BE96 Q37466453-D5102C74-F0D1-4AC3-ABD7-DBDDCBBC555A Q37828027-CA2388F0-1A4A-4206-B089-028ABA93DE9F Q37833072-C734FA2C-B926-4172-9103-7622D77CD404 Q38131440-2CB83A66-8C4F-4A43-AEC8-AC384A426071 Q38197158-6BD93FF4-AAE1-4636-A4EA-17F559F2485D Q38247426-D3590D37-D5A6-4625-859C-1689E42E363C Q38334585-4C238ED0-EB87-40CD-8F3F-EAA0AC80EAA4 Q39312961-4E75F287-BC52-4C72-9C99-E9A0BD7E7E88 Q39918562-3FABA755-51D6-46AB-9F1E-B14DC32F6A3D Q41473670-380572FD-557F-4F3C-962C-DFA0D6B04CED Q42138626-CA910EF6-F03E-46E2-B6C0-AFF328D36641 Q43324282-9AD6A004-4931-4F1F-B804-8FA7691E3C63 Q43713519-3A6EFA6F-F9C3-4724-B25B-4E2B158B84C4 Q45161788-E68BE71A-37CD-4E27-957F-B74DFB6B7928 Q45182465-EBEC63F8-27C6-4F52-BB5D-942F3AC98188 Q45716353-646BE581-C7A3-45C4-8680-AB5A9A6BEBB3 Q46455772-0B0182F7-E756-4FC9-8218-970263AEC704 Q47630409-D1907C58-09A7-4C4E-83F9-F343EB22C5E6 Q47824565-CC768DE4-B2EB-4882-81A9-73F79322FE54 Q48383156-C533950B-5DFF-4046-B01C-EA95F7F57B05 Q50728869-F32C5840-5509-4E4E-966F-357FB2C74A5E Q53632849-17B6BE93-4402-4EC8-A8FC-D6A9B96E715B Q55427191-0022D6E9-8F21-4DF6-862A-B635959A081C Q56832487-B32378B0-4066-4CA3-932F-F9B08D1AAAD2

P2860

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature.

http://www.wikidata.org/entity/Q34564716

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Are health care providers who ...... ta-analysis of the literature.

@ast

Are health care providers who ...... ta-analysis of the literature.

@en

Are health care providers who ...... ta-analysis of the literature.

@nl

type

label

Are health care providers who ...... ta-analysis of the literature.

@ast

Are health care providers who ...... ta-analysis of the literature.

@en

Are health care providers who ...... ta-analysis of the literature.

@nl

prefLabel

Are health care providers who ...... ta-analysis of the literature.

@ast

Are health care providers who ...... ta-analysis of the literature.

@en

Are health care providers who ...... ta-analysis of the literature.

@nl

P1433

Q34564716-8CFBAE18-9FC0-4739-A384-DB4BFB5743AB

P1476

Q34564716-3A2BE914-76DA-4247-9F27-A5005A14B587

P2093

Q34564716-0023D007-F089-4C88-9545-8E59F3722D93

Q34564716-1D0C0F6E-E3C0-4548-B1A3-ACD116C905CE

Q34564716-69D91D83-A756-4E72-9375-A9400BECE757

Q34564716-7FFF3531-32E2-4830-B91D-EA529EFCD023

Q34564716-B46AA041-65E0-4ECC-945B-A86BDE9DD092

Q34564716-C381CBE6-7FC5-4A5D-8DA4-2486839185E7

Q34564716-E93DD644-365B-46FC-856B-0146F2397AA1

P2860

Q34564716-1C880B00-DCD8-468F-9CEB-8DFD0DDCB04A

Q34564716-463F4D42-35E7-432C-BFCE-7857C2BDFC62

Q34564716-464C3E6B-11D7-436A-9C85-733A17F0374D

Q34564716-503FF1C2-01F3-4129-9D47-B678F398CBA3

Q34564716-62DF7950-7B8F-4062-A291-18E7166BBA40

Q34564716-725B82B0-B4A6-4345-8BB4-0C6DBC9D3D3C

Q34564716-8CF5C4FB-97E5-475B-983D-7E4898E1FF2D

Q34564716-9A3208B6-46E0-43DE-8EE5-1974C97DC491

Q34564716-BF9266D8-EF6E-4008-B9F8-0BBBE0700EE9

Q34564716-C3B7E1A6-140E-4F86-B0EF-32A1E1D3B0C4

P304

Q34564716-339B39AB-0F76-4541-BFE4-AA850FB1B3FC

P31

Q34564716-4295AD6D-42EF-49E1-85DB-2EA1A715FAFD

Q34564716-554c85b3-49c9-477e-88b4-33e0c480226d

P356

Q34564716-11E7F0A9-5BA0-45FF-8882-7A01F78EEE9D

P433

Q34564716-37D36C79-11D6-4BEC-AADB-33B1E4C7F237

P478

Q34564716-DA8F5ECC-F3A2-4B78-8F8A-57417AEFB0FE

P577

Q34564716-3DDE5A26-A3DF-4C76-8D2C-7C02838BE288

P5875

Q34564716-C802A60E-6839-45F6-9CB0-853A8B6D685D

P698

Q34564716-02125703-F72A-4CAF-B2CD-789367FAEDB6

P921

Q34564716-111FE51D-A100-49B6-908E-A06084457F5D

P356

1078155205JP155OA

P1433

Journal of Oncology Pharmacy Practice

P1476

Are health care providers who ...... ta-analysis of the literature.

@en

P2093

Brent Zanke

http://www.w3.org/2001/XMLSchema#string

Debbie Milliken

http://www.w3.org/2001/XMLSchema#string

Esther Green

http://www.w3.org/2001/XMLSchema#string

George Dranitsaris

http://www.w3.org/2001/XMLSchema#string

Mary Johnston

http://www.w3.org/2001/XMLSchema#string

Susan Poirier

http://www.w3.org/2001/XMLSchema#string

Trudi Schueller

http://www.w3.org/2001/XMLSchema#string

P2860

A study of occupational exposure to antineoplastic drugs and fetal loss in nurses

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality

Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.

Second cancers after breast cancer treatment.

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

P304

69-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1078155205JP155OA

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7308103

http://www.w3.org/2001/XMLSchema#string

P698

16465719

http://www.w3.org/2001/XMLSchema#string

P921